Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Hydrogen Bromide | HCID 260 | — |
| Reactant | Potassium Iodide | HCID 4875 | — |
| Reactant | (Chloromethyl)cyclopropane | HCID 80013 | — |
| Reactant | Sodium Bicarbonate | HCID 516892 | — |
| Reactant | HCID 20343882 | HCID 20343882 | — |
| Solvent | Water | HCID 962 | — |
| Solvent | Diethyl Ether | HCID 3283 | — |
| Solvent | Chloroform | HCID 6212 | — |
| Solvent | Dimethylformamide | HCID 6228 | — |
| Product | HCID 20343939 | HCID 20343939 | — |
Reaction Steps
A mixture of 2.0 g of 10,11-dihydro-11-oxospiro-[dibenz(b,f)-oxepin-10,4'-piperidine], free base of Example 3, 0.74 g of chloromethylcyclopropane, 1.8 g of sodium bicarbonate and 1.8 g of potassium iodide in 15 ml of dimethylformamide is stirred at 70°-80° C. for 16 hours. The resulting suspension is permitted to cool before being diluted with ether and water. The organic phase is successively dried, filtered and concentrated under vacuum, leaving a viscous oil. The oil is dissolved in chloroform and the chloroform solution is passed through an alumina column, with ether as an eluant. The purified oil is dissolved in ether where it is converted to its hydrobromic acid salt which is recrystallized from a methyl alcohol-ether mixture to provide rhombic crystals, mp 258°-259° C., (dec) of 1'-cyclopropylmethyl-10,11-dihydro-11-oxospiro[dibenz(b,f)oxepin-10,4'-piperidine]hydrobromide.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US04198418 |
|---|
| Source dataset | uspto-grants-1980_04 |
|---|
| ORD ID | ord-d927525e21c24bebb9adbad12692cdbe |
|---|
| Source note | uspto-grants-1980_04 |
|---|